For many people in the diaspora, managing health in the UK often means balancing long-term conditions, multiple prescriptions, and trust in a healthcare system that may feel very different from home. From diabetes medication to mental health treatments, everyday medicines play a major role in daily life for millions of Nigerians and other migrant communities living abroad.
At Chijos News, we break down complex UK health research into clear, relatable stories that matter to diaspora families. A new scientific review by the Medicines and Healthcare products Regulatory Agency (MHRA) and the University of Glasgow sheds light on how some commonly used medicines may quietly influence gut bacteria, potentially shaping how treatments work, how side effects appear, and why people respond differently to the same drug.
Everyday Medicines and the Hidden Role of Gut Bacteria
New research suggests that it is not only antibiotics that affect gut bacteria. According to a review published on 23 December in the journal Nature npj Antimicrobials and Resistance, several everyday medicines may also alter the delicate balance of bacteria living in the human gut.
The study, led by Shirley Do Nascimento and colleagues from the MHRA and the University of Glasgow, brings together growing evidence that medicines used to treat conditions such as diabetes and mental illness can subtly reshape the gut microbiome. These changes may influence how medicines are absorbed, how effective they are, and how the body reacts when multiple treatments are taken together.
Why the Gut Microbiome Matters
The gut microbiome is made up of trillions of bacteria that play a vital role in digestion, immunity, and metabolism. When this balance is healthy, it helps the body function properly. When it is disrupted, it can affect everything from inflammation to weight and energy levels.
While antibiotics are widely known to disrupt gut bacteria, this review highlights that non-antibiotic medicines may also have an impact, though often in more subtle ways. These changes may not always be immediately noticeable but could influence long-term health outcomes.
How Common Medicines May Be Affecting the Gut
The review highlights evidence that metformin, one of the most commonly prescribed medicines for type 2 diabetes, alters gut bacteria in ways that may explain both its benefits and some of its side effects. For some patients, changes to gut bacteria may contribute to improved blood sugar control, while for others they may explain symptoms such as bloating or diarrhoea.
The research also points to studies showing that some antipsychotic medicines can disrupt gut bacteria linked to weight gain and metabolic changes. This could help explain why certain patients experience significant physical side effects while others do not.
Understanding Why People Respond Differently to Medicines
One of the most important implications of the research is its potential to explain why people taking the same medicine can have very different experiences. According to Dr Chrysi Sergaki, senior author of the study and Head of Microbiome at the MHRA, understanding how medicines interact with gut bacteria could help explain differences in treatment response and side effects.
This growing body of evidence may allow regulators, researchers, and healthcare professionals to better predict who will benefit most from certain medicines and who may be at higher risk of adverse reactions.
Implications for Antibiotic Resistance and Safer Treatments
The findings may also play a role in efforts to slow the spread of antimicrobial resistance. The gut is a major reservoir for bacteria, including those that carry resistance genes. When medicines disrupt the balance of gut bacteria, resistant strains may gain an advantage.
By identifying medicines that are less disruptive to the microbiome, researchers hope to protect the effectiveness of antibiotics and reduce long-term risks linked to resistance.
Dr Anastasia Theodosiou of the University of Glasgow described the study as an important step toward recognising the microbiome as something that needs protection, not just treatment.
How the MHRA Is Responding to the Findings
The MHRA is now working with researchers and innovators to develop updated standards for studying how medicines affect the gut microbiome during drug development. This work may also extend to other microbiomes, such as the vaginal microbiome, where appropriate.
The agency is also exploring new ways to predict side effects and interactions between medicines before they reach patients. This includes the Yellow Card Biobank, which links reports of suspected side effects with genetic and biological data, helping researchers understand why adverse reactions occur in some people but not others.
In addition, the MHRA is supporting new studies using artificial intelligence and anonymised NHS data to predict potential side effects from combinations of medicines. This is particularly important as millions of people in the UK take more than one medicine at the same time.
What This Means for Patients and Diaspora Communities
For patients, including many in the Nigerian and wider African diaspora who may be managing long-term conditions, the message remains clear. Medicines should be taken exactly as prescribed, and treatments should not be stopped or changed without professional advice.
However, this research highlights the importance of open conversations with healthcare professionals, especially for those experiencing side effects or taking multiple medications. Reporting suspected side effects through the MHRA Yellow Card scheme helps improve medicine safety for everyone.
This research marks a significant shift in how scientists and regulators understand medicines, moving beyond a one-size-fits-all approach. By recognising the role of gut bacteria, the future of healthcare may become more personalised, safer, and more effective.
At Chijos News, we continue to spotlight health stories that matter to diaspora communities, ensuring vital UK medical research is accessible, relevant, and empowering for readers navigating healthcare far from home.